Aniket Naha

6PUBLICATIONS
11CO-AUTHORS
Major global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Cancer geneticsProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2025
Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach.

Elizabeth Annie George, Aniket Naha, Sudha Ramaiah

|Jun 11, 2025
Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis.

Elizabeth Annie George, Aniket Naha, H Soundharya

|Mar 27, 2023
Novel Antimicrobial Peptide SAAP Mutant as a Better Adjuvant to Sulbactam-Based Treatments Against Clinical Strains of XDR Acinetobacter baumannii.

Aniket Naha, Sudha Ramaiah

|Sep 07, 2022
Structural chemistry and molecular-level interactome reveals histidine kinase EvgS to subvert both antimicrobial resistance and virulence in Shigella flexneri 2a str. 301.

Aniket Naha, Sudha Ramaiah

|Oct 01, 2021
Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam-durlobactam holds promise for therapeutic intervention.

Aniket Naha, Saranya Vijayakumar, Binesh Lal

|May 17, 2021
In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis.

Soumya Basu, Aniket Naha, Balaji Veeraraghavan

Pageof 1

Frequent Collaborators

6 joint publications

Sudha Ramaiah

3 joint publications

Anand Anbarasu

2 joint publications

Balaji Veeraraghavan

2 joint publications

Elizabeth Annie George